Related Experiment Videos
Prognostic factors in non-Hodgkin's lymphomas
Acta Haematologica
|January 1, 1985
Summary
Erythrocyte sedimentation rate (ESR) is a key prognostic factor for non-Hodgkin's lymphoma survival. This simple blood test effectively predicts patient outcomes, outperforming other clinical factors in many cases.
Area of Science:
- Hematology
- Oncology
- Clinical Pathology
Background:
- Non-Hodgkin's lymphoma (NHL) prognosis is influenced by various factors.
- Accurate prognostic indicators are crucial for tailoring treatment strategies.
Purpose of the Study:
- To identify significant prognostic factors for survival in NHL patients.
- To evaluate the predictive value of erythrocyte sedimentation rate (ESR) and other parameters.
Main Methods:
- Analysis of prognostic factors in 67 homogeneously staged and treated NHL patients.
- Multiple regression factor analysis of scrutinized parameters.
- Validation with an additional 28 control patients.
Main Results:
- Erythrocyte sedimentation rate (ESR), dichotomized at 35 mm/hr, was the strongest prognosticator.
- Histologic type (Kiel classification) was a significant short-term prognosticator.
- Clinical stage showed prognostic value, particularly for longer-term survival.
Conclusions:
- ESR is a simple, yet powerful, prognostic tool for non-Hodgkin's lymphoma.
- ESR's utility in predicting patient survival warrants its routine consideration.
- Combining ESR with histologic type and stage may optimize prognostic accuracy.